Amyotrophic Lateral Sclerosis (ALS) Market
Amyotrophic Lateral Sclerosis (ALS) Market Scope:
Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Amyotrophic Lateral Sclerosis (ALS) Market Size and Growth
The ALS market is experiencing significant growth driven by rising disease prevalence and increasing R&D investments. As of 2023, the global market size is estimated to reach approximately $1.5 billion. Innovative therapies, enhanced awareness, and supportive healthcare policies are key factors influencing market dynamics in this evolving landscape. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ "Mitsubishi Tanabe Pharma"
◍ "Sanofi"
◍ "Mylan Pharma"
◍ "Apotex"
◍ "Glemark Generics"
◍ "Covis Pharma"
◍ "Sun Pharma"
◍ "Lunan Pharma"
The ALS market features key players like Mitsubishi Tanabe Pharma, Sanofi, and Mylan Pharma, focusing on innovative therapies and generics. These companies enhance market growth through research, collaborations, and expanding treatment access. Notable revenues include Mitsubishi Tanabe Pharma's $1.1 billion (2021) in ALS treatments and Sanofi's broader neurology segment growth.
Request Sample Report
Market Segmentation
By Application
"Hospital" ◍ "Drugs Store" ◍ "Other"
Request Sample Report
By Product
"Riluzole"
"Edaravone (Radicava)"
"Other"
$ 354.00 Million
Request Sample Report
